Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigehara

Showing results (351-360 of 378) with videos related to

Pageof 38
Sort By:
Clinical Immunology (Orlando, Fla.)|April 2, 2015
Alteration of circulating type 2 follicular helper T cells and regulatory B cells underlies the comorbid association of allergic rhinitis with bronchial asthmaRyuta Kamekura, Katsunori Shigehara, Satsuki Miyajima, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 4, 2026
Long-term changes and risk factors for persistent cough and sputum in adult patients with asthma treated by Japanese specialists: The SARAS study (1997-2023)Chikako Kitamura, Satsuki Miyajima, Hiroshi Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2024
Comprehensive analysis of perioperative hypotension in photodynamic diagnosis-assisted transurethral resection of bladder tumor with 5-aminolevulinic acidTakahiro Nohara, Atsuya Takimoto, Rei Shinzawa, et al.
The Prostate|July 2, 2026
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPCKohei Hashimoto, Kouji Izumi, Takashi Shima, et al.
Biomedicines|October 27, 2022
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate CancerHiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, et al.
European Urology Open Science|July 11, 2022
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled TrialKouji Izumi, Takashi Shima, Koji Mita, et al.
The Prostate|September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCaNobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
Scientific Reports|July 22, 2025
The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinomaKengo Shigehara, Noriko Kawai, Tomohide Shirosaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2026
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCaSeiji Hoshi, Kouji Izumi, Satoru Meguro, et al.
Scientific Reports|January 13, 2021
Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cellsTomoyuki Makino, Kouji Izumi, Kaoru Hiratsuka, et al.
Pageof 38

Showing results (351-360 of 378) with videos related to

Sort By:
Pageof 38
Clinical Immunology (Orlando, Fla.)|April 2, 2015
Alteration of circulating type 2 follicular helper T cells and regulatory B cells underlies the comorbid association of allergic rhinitis with bronchial asthmaRyuta Kamekura, Katsunori Shigehara, Satsuki Miyajima, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|February 4, 2026
Long-term changes and risk factors for persistent cough and sputum in adult patients with asthma treated by Japanese specialists: The SARAS study (1997-2023)Chikako Kitamura, Satsuki Miyajima, Hiroshi Tanaka, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 30, 2024
Comprehensive analysis of perioperative hypotension in photodynamic diagnosis-assisted transurethral resection of bladder tumor with 5-aminolevulinic acidTakahiro Nohara, Atsuya Takimoto, Rei Shinzawa, et al.
The Prostate|July 2, 2026
The Lowest PSA Level Achieved Before CRPC Predicts Abiraterone Response But Not Enzalutamide Response in Metastatic CRPCKohei Hashimoto, Kouji Izumi, Takashi Shima, et al.
Biomedicines|October 27, 2022
Serum CCL2 Is a Prognostic Biomarker for Non-Metastatic Castration-Sensitive Prostate CancerHiroaki Iwamoto, Kouji Izumi, Ryunosuke Nakagawa, et al.
European Urology Open Science|July 11, 2022
Enzalutamide Versus Abiraterone plus Prednisolone Before Chemotherapy for Castration-resistant Prostate Cancer: A Multicenter Randomized Controlled TrialKouji Izumi, Takashi Shima, Koji Mita, et al.
The Prostate|September 20, 2024
Dose modification in enzalutamide and abiraterone plus prednisolone for castration-resistant prostate cancer: A subanalysis from the ENABLE study for PCaNobumichi Tanaka, Kouji Izumi, Yasushi Nakai, et al.
Scientific Reports|July 22, 2025
The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinomaKengo Shigehara, Noriko Kawai, Tomohide Shirosaki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|May 20, 2026
Efficacy and Safety of Enzalutamide and Abiraterone in CRPC Patients With a History of Other Cancers: A Sub-Analysis of the ENABLE Study for PCaSeiji Hoshi, Kouji Izumi, Satoru Meguro, et al.
Scientific Reports|January 13, 2021
Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol in human renal cancer cellsTomoyuki Makino, Kouji Izumi, Kaoru Hiratsuka, et al.
Pageof 38